Netris Pharma
🏢 View company profile →4Patents
4Active
4Granted
40Portfolio score
Filing activity: Sep 12, 2013 → Oct 18, 2019
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US10494427B2 | Anti-netrin-1 antibody | Chemistry; Metallurgy | 1 | Active |
| US12162932B2 | Combined treatment with Netrin-1 interfering drug and immune checkpoint inhibitors drugs | Chemistry; Metallurgy | 0 | Active |
| US9895439B2 | Combined treatment with netrin-1 interfering drug and chemotherapeutic drug | Chemistry; Metallurgy | 0 | Active |
| US11648309B2 | Anti-netrin-1 antibody | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.